ClinicalTrials.govpublic full text
Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma
head and neck squamous cell carcinoma, neoadjuvant therapy, immunotherapy, cdk4/6 inhibitor, locally advanced head and neck squamous cell carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 894205
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.